In this webinar Dr. Francesco Imperatore, Field Application Specialist at Cellply, discusses a novel approach to uncover hidden killing activity within a cell therapy population and reveal which subsets have the potential to exhibit a dominant role in anti-tumor activity.
Duration: 30 mins
Highlights:
- See how measuring multiple functional and phenotypic properties on the same immune cells, without pre-sorting, can identify hidden cells with unique killing characteristics.
- Hear how the VivaCyte platform provides a unique combination of single-cell resolution, flexible assay design, and automation at scale, while using 10-fold less cells than traditional analysis techniques.
- Learn about real-world examples of how these new data are providing insights for therapy developers not previously available, and influencing better candidate selection.